Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000943663-19-000207
Filing Date
2019-11-04
Accepted
2019-11-01 21:46:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A innovatus13da_112019.htm SC 13D/A 136365
  Complete submission text file 0000943663-19-000207.txt   138107
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc (Subject) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90660 | Film No.: 191188137
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 777 THIRD AVENUE 25TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 25TH FLOOR NEW YORK NY 10017 212.698.4595
Innovatus Life Sciences Lending Fund I, LP (Filed by) CIK: 0001692825 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A